Literature DB >> 24354416

The effects of luteolin on the intestinal ischemia/reperfusion injury in mice.

Barış Rafet Karakaş1, Fatih Davran, Gülsüm Özlem Elpek, S Halide Akbaş, Kemal Hakan Gülkesen, Nurullah Bülbüller.   

Abstract

The purpose of this study is to investigate the potential protective effect of the flavonoid Luteolin on ischemia-reperfusion (IR) injury in mouse intestine, which has not previously been studied. Twenty-four female C57BL/6 mice were randomly assigned to four groups, each consisting of 6 mice: a sham group (laparotomy, but no IR injury), a sham + Luteolin group (no IR, and Luteolin was administered intraperitoneally 30 min after laparotomy), IR group (30 min occlusion of the superior mesenteric artery (SMA) then 2 hr' reperfusion), IR + Luteolin (30 min occlusion of the SMA then 2 hr' reperfusion; Luteolin was administered intraperitoneally before reperfusion). Intestine tissues were harvested from the mice for histopathological and biochemical analysis. Total oxidant status (TOS) and total antioxidant capacity (TAC) of the intestinal tissues were measured using Erel's method. Oxidative stress index (OSI) was calculated using the TOS/TAC ratio. Intestinal histological changes were significantly decreased in the IR + Luteolin group compared with the IR group (p = .037). TOS tissue levels were also significantly decreased in the IR + Luteolin group compared with the IR group (p = .005). TAC levels did not increase significantly in the IR treatment group and were not affected by Luteolin treatment (p > .05). The results of this study show that Luteolin administration provides considerable protection against IR injury in the mouse intestine.

Entities:  

Keywords:  Luteolin; acute mesenteric ischemia; flavonoid; intestine; ischemia-reperfusion injury; mice

Mesh:

Substances:

Year:  2013        PMID: 24354416     DOI: 10.3109/08941939.2013.865819

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  5 in total

1.  Luteolin alleviates ulcerative colitis through SHP-1/STAT3 pathway.

Authors:  Bo-Lin Li; Dan-Yang Zhao; Peng-Li Du; Xiao-Tian Wang; Qian Yang; Yan-Ru Cai
Journal:  Inflamm Res       Date:  2021-05-20       Impact factor: 4.575

2.  Fetuin-A exerts a protective effect against experimentally induced intestinal ischemia/reperfusion by suppressing autophagic cell death.

Authors:  Nanees F El-Malkey; Amira E Alsemeh; Wesam Mr Ashour; Nancy H Hassan; Husam M Edrees
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-02

3.  Enhancement of Exercise Performance by 48 Hours, and 15-Day Supplementation with Mangiferin and Luteolin in Men.

Authors:  Miriam Gelabert-Rebato; Julia C Wiebe; Marcos Martin-Rincon; Victor Galvan-Alvarez; David Curtelin; Mario Perez-Valera; Julian Juan Habib; Alberto Pérez-López; Tanausú Vega; David Morales-Alamo; Jose A L Calbet
Journal:  Nutrients       Date:  2019-02-06       Impact factor: 5.717

4.  Mangifera indica L. Leaf Extract in Combination With Luteolin or Quercetin Enhances VO2peak and Peak Power Output, and Preserves Skeletal Muscle Function During Ischemia-Reperfusion in Humans.

Authors:  Miriam Gelabert-Rebato; Julia C Wiebe; Marcos Martin-Rincon; Nigel Gericke; Mario Perez-Valera; David Curtelin; Victor Galvan-Alvarez; Laura Lopez-Rios; David Morales-Alamo; Jose A L Calbet
Journal:  Front Physiol       Date:  2018-06-08       Impact factor: 4.566

5.  Protective effect of luteolin on skin ischemia-reperfusion injury through an AKT-dependent mechanism.

Authors:  Gang Chen; Hugang Shen; Linlin Zang; Zhonglan Su; Jilong Huang; Yong Sun; Hongwei Wang
Journal:  Int J Mol Med       Date:  2018-10-02       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.